BX-4005

N/A

Report date: 2024/10/15 18:11:05
NME

Base Information

Drug NameBX-4005
Drug Alias NameBX-4005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen activated protein kinase kinase kinase 1 inhibitors
TargetsMitogen activated protein kinase kinase kinase 1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Benxin Pharmaceutical Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Benxin Pharmaceutical Co., Ltd.
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A